text
"['\nXII. 상세표\n1. 연결대상 종속회사 현황(상세)\n☞ 본문 위치로 이동\n(단위 : 백만원)\n상호\n설립일\n주소\n주요사업\n최근사업연도말자산총액\n지배관계 근거\n주요종속회사 여부\nDong-A America Corp\n1990.01.09\n17215 Studebaker Road, Suite #335,Cerritos, CA 90703, USA\n의약품 판매\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0854\xa0\n기업 의결권의 과반수 소유\n미해당\n동아참메드(주)\n2005.02.02\n경기도 군포시 고산로 148번길 17(당정동) 군포 IT밸리 A동 13층 동아참메드\n의료기기 제조 및 판매\n\xa0 \xa0 \xa0 \xa0 \xa0 62,078\xa0\n기업 의결권의 과반수 소유\n미해당\nDong-A ST India Pvt., Ltd\n2021.12.03\n714, B-wing, Atrium-215 building, Andgeri Kurla Road, Andheri East, Mumbai-400069, India\xa0\n의약품판매\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0329\xa0\n기업 의결권의 과반수 소유\n미해당\nNeurobo Pharmaceuticals, Inc\n2014.10.30\n200 BERKELEY ST., FL 19, BOSTON, MA, 02116\n연구개발\n\xa0 \xa0 \xa0 \xa0 \xa0 29,373\xa0\n기업 의결권의 과반수 소유\n미해당\n앱티스(주)\n2016.08.01\n경기도 수원시 권선구 산업로 156번길 142-10, A동 815호\n연구개발\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa09,688\xa0\n기업 의결권의 과반수 소유\n미해당\n2. 계열회사 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 12월 31일\n)\n(단위 : 사)\n상장여부\n회사수\n기업명\n법인등록번호\n상장\n4\n동아쏘시오홀딩스(주)\n110111-0017990\n동아에스티(주)\n110111-5079713\n에스티팜(주)\n154511-0039704\nNeurobo Pharmaceuticals Inc\n해외법인\n비상장\n26\n동아제약(주)\n110111-5079739\n에스티젠바이오(주)\n120111-0756728\n(주)수석\n110111-0107973\n용마LOGIS(주)\n110111-0245369\n디에이인포메이션(주)\n110111-3479478\n(주)인더스파크\n165011-0030519\n(주)아벤종합건설\n130111-0013522\n동아오츠카(주)\n134111-0007761\n(주)동천수\n171411-0019799\n디에스프론티어(주)\n134511-0342771\n동아참메드(주)\n135111-0074206\n(주)얼수\n171411-0032874\n용인기흥PFV(주)\n110111-8682646\n앱티스(주)\n110111-6134722\nNeon Global co., Ltd.\n해외법인\nDong-A America Corp.\n〃\n소주동아음료\n〃\nJ Box co., Limited\n〃\nScion Global co., Limited\n〃\nSTP America research Corp\n〃\nCHAMMED(TIANJIN) COMMERCIAL., LTD.\n〃\nANAPATH SERVICES\n〃\nANAPATH RESEARCH\n〃\nLevatio Therapeutics, LLC.\n〃\nDong-A ST India Pvt.\n〃\nVernagen\n〃\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nDong-A Brasil Farmaceutica Ltda\n비상장\n2013.04.01\n경영참여\n2,194\n3,156,754\n\xa099.10\n305\n-3,156,754\n-305\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\xa0\n-\n\xa0 \xa0 \xa0 \xa0 \xa0-\n-\n-\nDong-A America Corporation\n비상장\n2014.11.28\n경영참여\n256\n300\n\xa0100.00\n256\n-\n-\n-\n300\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 100.00\n256\n854\n0\n동아참메드\n비상장\n2021.09.02\n경영참여\n33,034\n70,000\n\xa0100.00\n7,673\n249,406\n25,362\n-\n319,406\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa073.71\n33,035\n62,078\n0\nDong-A ST India Pvt., Ltd\n비상장\n2021.12.03\n경영참여\n109\n693,000\n\xa099.00\n109\n-\n-\n-\n693,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa099.00\n109\n329\n73\nNEUROBO PHARMACEUTICALS, INC.\n상장\n2018.04.27\n경영참여\n43,493\n1,553,669\n\xa048.87\n20,466\n1,250,000\n-\n-7,101\n2,803,669\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa057.15\n13,365\n29,373\n-20,134\n앱티스(주)\n비상장\n2023.12.19\n경영참여\n31,383\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 \xa0-\n1,526,980\n31,383\n-\n1,526,980\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa051.47\n31,383\n9,688\n-8,661\n(주)레드엔비아\n비상장\n2019.03.29\n일반투자\n4,000\n333,334\n\xa040.60\n4,000\n26,000\n1,508\n-\n359,334\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa042.22\n5,508\n9,372\n-15,098\n인하브바이오텍7성장사모투자 합자회사\n비상장\n2020.12.17\n일반투자\n3,901\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa046.95\n3,901\n-\n-\n-3,901\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa046.95\n\xa0 \xa0 \xa0 \xa0 \xa0-\n7,819\n-128\n메리츠-엔에스 글로벌바이오투자조합\n비상장\n2018.03.27\n단순투자\n2,905\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 10.34\n758\n-\n-\n-188\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa010.34\n570\n15,303\n-296\n글로벌바이오성장제3호투자조합\n비상장\n2021.06.22\n단순투자\n3,880\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 16.53\n3,424\n-\n-\n-76\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 7.78\n3,348\n42,996\n-1,222\n신한-타임폴리오바이오육성투자조합\n비상장\n2023.06.29\n단순투자\n1,200\n-\n-\n-\n-\n1,200\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 9.70\n1,200\n12,420\n-150\n노벨파마\n비상장\n2020.07.29\n단순투자\n1,003\n92\n\xa00.50\n241\n-\n-\n232\n92\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 0.50\n473\n8,030\n-13,439\n노벨티노빌리티\n비상장\n2021.02.09\n단순투자\n1,000\n24,295\n\xa01.89\n1,148\n-\n-\n37\n24,295\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1.34\n1,185\n32,125\n-6,896\nGenEdit INC\n비상장\n2023.02.14\n단순투자\n1,275\n-\n-\n\xa0-\n280,567\n1,275\n-\n280,567\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1.19\n1,275\n31,428\n-18,298\n메쥬\n비상장\n2021.11.30\n단순투자\n3,000\n16,608\n\xa04.57\n2,500\n1,938\n500\n730\n18,546\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 4.50\n3,730\n8,612\n-2,803\nAntiva\n비상장\n2020.10.29\n단순투자\n613\n2,441,936\n\xa02.34\n706\n213,242\n165\n396\n2,655,178\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 1.69\n1,267\n8,502\n-2,534\n이지메디컴\n비상장\n2001.09.06\n단순투자\n200\n80,000\n\xa00.35\n242\n-\n\xa0-\n20\n80,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 0.35\n262\n270,648\n8,263\n호유코리아\n비상장\n2005.01.27\n단순투자\n540\n5,400\n\xa020.00\n494\n-\n-\n17\n5,400\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa020.00\n511\n3,136\n47\n오스테오시스\n비상장\n2005.09.01\n단순투자\n31\n139,372\n\xa05.38\n1,636\n-139,372\n-1,636\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n-\n\xa0 \xa0 \xa0 \xa0 -\n34,984\n2,282\nCSTV\n비상장\n2011.01.28\n단순투자\n3,000\n600,000\n\xa00.97\n5,627\n-\n-\n1,714\n600,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 0.97\n7,341\n472,900\n36,367\nJTBC\n비상장\n2011.02.23\n단순투자\n4,936\n987,147\n\xa00.86\n493\n-\n-\n-49\n987,147\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 0.86\n444\n390,413\n-66,744\n사이언스메딕\n비상장\n2015.04.30\n단순투자\n223\n4,445\n\xa010.00\n307\n-\n-\n33\n4,445\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa010.00\n340\n9,259\n567\n에스엘바이젠\n비상장\n2019.11.29\n단순투자\n6,385\n473,000\n\xa02.94\n2,637\n-\n-\n247\n473,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 2.45\n2,884\n37,715\n-12,482\nPT Combiphar\n비상장\n2017.06.30\n단순투자\n10,841\n5,663\n\xa06.32\n5,976\n-\n-\n-11\n5,663\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 6.32\n5,965\n9,469\n20\nBeactica AB\n비상장\n2018.03.16\n단순투자\n448\n11,504\n\xa03.40\n689\n-\n-\n-322\n11,504\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 3.22\n367\n4,423\n-1,360\nMthera Pharma\n비상장\n2023.07.24\n단순투자\n1,000\n-\n-\n-\n5,000\n1,000\n-\n5,000\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 2.75\n1,000\n-\n-\n합 계\n-\n-\n63,588\xa0\n257,007\n60,452\n-8,222\n-\n-\n115,818\n-\n-\n']"
